Avivagen Inc (CHEXF) 0.0630 $CHEXF
Avivagen Summarizes Final Swine Trial Results
ACCESSWIRE - Wed Feb 11, 6:37AM CST
OTTAWA, ON / ACCESSWIRE / February 11, 2015 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides a summary of the final results of the swine trial that was run by the National Institute of Animal Sciences for Vietnam.
VIV.VN: 0.070 (unch)
Avivagen Provides Update Regarding Proof of Concept Work On Permanent Non-Surgical Sterilization
ACCESSWIRE - Tue Feb 03, 6:33AM CST
Ottawa, ON / ACCESSWIRE / February 3, 2015 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides an update on the proof of concept work with its optioned technology for the permanent sterilization of female mammals - targeted to eliminate the need for surgical spaying.
Avivagen Announces Attendance at AlphaNorth Capital Conference January 16 & 17, 2015
ACCESSWIRE - Fri Jan 16, 6:32AM CST
Ottawa, ON / ACCESSWIRE / Jan 16 2015 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending the AlphaNorth Capital Conference on January 16th and 17th, 2015.
VIV.VN: 0.070 (unch)
Avivagen Announces Closing of Private Placement
ACCESSWIRE - Wed Dec 17, 6:07AM CST
Ottawa, ON / ACCESSWIRE / December 17, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them announces the closing of its previously disclosed non-brokered private placement.
Avivagen Announces Proposed Private Placement
ACCESSWIRE - Thu Nov 27, 7:41AM CST
Ottawa, ON / ACCESSWIRE / November 27, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), announces that it intends to complete a non-brokered private placement of units for gross proceeds of $1.0 million. Avivagen is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Peer-Reviewed Publication of Independent Research Provides Further Supporting Evidence for Efficacy of Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Wed Nov 26, 6:06AM CST
Ottawa, ON / ACCESSWIRE / Nov 26, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF). Today a leading scientific publication published results of a study of the utility and mechanisms of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. The article is the outcome of work by independent scientists from the University of Calgary and the University of Alberta. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Announces Results from Efficacy Studies of Natural Alternative to Antibiotic Use in Swine and Poultry
ACCESSWIRE - Mon Nov 24, 6:06AM CST
OTTAWA, ONTARIO / ACCESSWIRE / November 24, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) announces preliminary results of independently conducted studies of the livestock utility of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Scientists Publish Supporting Evidence about Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Fri Oct 31, 1:05PM CDT
Ottawa, ON / ACCESSWIRE / October 31, 2014 / Today the leading journal PLOS ONE published research that provides underlying scientific support for a fundamentally new type of natural alternative to the use of antibiotics in livestock feeds for growth promotion and disease prevention. The paper is the result of work by both independent and company scientists. Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Announces Launch of New Corporate Website
ACCESSWIRE - Tue Oct 14, 7:11AM CDT
Ottawa, ON / ACCESSWIRE / October 14, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the launch of its new corporate website.
Avivagen Announces Feature Article on OXC-Beta Swine Results in Ontario Hog Farmer's Magazine
ACCESSWIRE - Thu Oct 02, 7:12AM CDT
Ottawa, ON / ACCESSWIRE / October 2, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the publication of a trade magazine article about the use of OxC-beta in Canadian swine.
Avivagen Announces CEO Update & Preliminary Study Results
ACCESSWIRE - Thu Sep 25, 7:09AM CDT
Ottawa, ON / ACCESSWIRE / September 25, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life of animals and the people who care for them, announces the release and website posting of a CEO update letter that includes a discussion of the preliminary results from two Asian livestock studies. In addition to reading the contents of the CEO update letter below, we encourage you to visit the Avivagen website to learn more about the company, at www.avivagen.com.
Avivagen Commences Study on Permanent and Non-Surgical Sterilization Technology
ACCESSWIRE - Wed Aug 13, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Aug 13 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the start of a proof-of-concept study on its optioned technology for the permanent sterilization of female mammals - that may eliminate the need for surgical spaying.
Avivagen Announces Aquaculture Trial Agreement With Nam Sai Farms of Thailand
ACCESSWIRE - Fri Jul 18, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Jul 18 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, today announced an agreement with Nam Sai Farms Co. Ltd. of the Kingdom of Thailand to conduct a trial to determine the effects of OxC-beta on the grow-out parameters of tilapia.
VIV.VN: 0.070 (unch)
Avivagen Announces Investor Conference Attendance In British Columbia, Canada July 17-19
ACCESSWIRE - Wed Jul 16, 9:17AM CDT
Ottawa, ON / ACCESSWIRE / Jul 16 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending an investor conference in the Canadian province of British Columbia.
VIV.VN: 0.070 (unch)
Avivagen Summarizes Final Swine Trial Results
ACCESSWIRE - Wed Feb 11, 6:37AM CST
OTTAWA, ON / ACCESSWIRE / February 11, 2015 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides a summary of the final results of the swine trial that was run by the National Institute of Animal Sciences for Vietnam.
VIV.VN: 0.070 (unch)
Avivagen Provides Update Regarding Proof of Concept Work On Permanent Non-Surgical Sterilization
ACCESSWIRE - Tue Feb 03, 6:33AM CST
Ottawa, ON / ACCESSWIRE / February 3, 2015 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides an update on the proof of concept work with its optioned technology for the permanent sterilization of female mammals - targeted to eliminate the need for surgical spaying.
Avivagen Announces Attendance at AlphaNorth Capital Conference January 16 & 17, 2015
ACCESSWIRE - Fri Jan 16, 6:32AM CST
Ottawa, ON / ACCESSWIRE / Jan 16 2015 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending the AlphaNorth Capital Conference on January 16th and 17th, 2015.
VIV.VN: 0.070 (unch)
Avivagen Announces Closing of Private Placement
ACCESSWIRE - Wed Dec 17, 6:07AM CST
Ottawa, ON / ACCESSWIRE / December 17, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them announces the closing of its previously disclosed non-brokered private placement.
Avivagen Announces Proposed Private Placement
ACCESSWIRE - Thu Nov 27, 7:41AM CST
Ottawa, ON / ACCESSWIRE / November 27, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), announces that it intends to complete a non-brokered private placement of units for gross proceeds of $1.0 million. Avivagen is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Peer-Reviewed Publication of Independent Research Provides Further Supporting Evidence for Efficacy of Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Wed Nov 26, 6:06AM CST
Ottawa, ON / ACCESSWIRE / Nov 26, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF). Today a leading scientific publication published results of a study of the utility and mechanisms of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. The article is the outcome of work by independent scientists from the University of Calgary and the University of Alberta. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Announces Results from Efficacy Studies of Natural Alternative to Antibiotic Use in Swine and Poultry
ACCESSWIRE - Mon Nov 24, 6:06AM CST
OTTAWA, ONTARIO / ACCESSWIRE / November 24, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) announces preliminary results of independently conducted studies of the livestock utility of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Scientists Publish Supporting Evidence about Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Fri Oct 31, 1:05PM CDT
Ottawa, ON / ACCESSWIRE / October 31, 2014 / Today the leading journal PLOS ONE published research that provides underlying scientific support for a fundamentally new type of natural alternative to the use of antibiotics in livestock feeds for growth promotion and disease prevention. The paper is the result of work by both independent and company scientists. Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
Avivagen Announces Launch of New Corporate Website
ACCESSWIRE - Tue Oct 14, 7:11AM CDT
Ottawa, ON / ACCESSWIRE / October 14, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the launch of its new corporate website.
Avivagen Announces Feature Article on OXC-Beta Swine Results in Ontario Hog Farmer's Magazine
ACCESSWIRE - Thu Oct 02, 7:12AM CDT
Ottawa, ON / ACCESSWIRE / October 2, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the publication of a trade magazine article about the use of OxC-beta in Canadian swine.
Avivagen Announces CEO Update & Preliminary Study Results
ACCESSWIRE - Thu Sep 25, 7:09AM CDT
Ottawa, ON / ACCESSWIRE / September 25, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life of animals and the people who care for them, announces the release and website posting of a CEO update letter that includes a discussion of the preliminary results from two Asian livestock studies. In addition to reading the contents of the CEO update letter below, we encourage you to visit the Avivagen website to learn more about the company, at www.avivagen.com.
Avivagen Commences Study on Permanent and Non-Surgical Sterilization Technology
ACCESSWIRE - Wed Aug 13, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Aug 13 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the start of a proof-of-concept study on its optioned technology for the permanent sterilization of female mammals - that may eliminate the need for surgical spaying.
Avivagen Announces Aquaculture Trial Agreement With Nam Sai Farms of Thailand
ACCESSWIRE - Fri Jul 18, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Jul 18 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, today announced an agreement with Nam Sai Farms Co. Ltd. of the Kingdom of Thailand to conduct a trial to determine the effects of OxC-beta on the grow-out parameters of tilapia.
VIV.VN: 0.070 (unch)
Avivagen Announces Investor Conference Attendance In British Columbia, Canada July 17-19
ACCESSWIRE - Wed Jul 16, 9:17AM CDT
Ottawa, ON / ACCESSWIRE / Jul 16 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending an investor conference in the Canadian province of British Columbia.
VIV.VN: 0.070 (unch)
